Inovio Pharamceuticals, Inc. Common Stock, $0.001 par value ATM EQUITY OFFERINGSM SALES AGREEMENTAtm Equity Offering Sales Agreement • November 9th, 2021 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • New York
Inovio Pharmaceuticals,, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time to or through BofA Securities, Inc. (“BofA”), RBC Capital Markets, LLC (“RBC”) or Oppenheimer & Co. Inc. (“OpCo”) as sales agent and/or principal (each an “Agent” and collectively, the “Agents”) shares (the “Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”), having an aggregate gross sales price of not exceed $300,000,000 on the terms set forth in this ATM Equity OfferingSM Sales Agreement. The Company agrees that whenever it determines to sell Shares directly to the Agents as principal it will enter into a separate written Terms Agreement (each, a “Terms Agreement”), in substantially the form of Annex I hereto, relating to such sale in accordance with Section 2(k) hereof. References herein to “this Agreement” or to matters contained “herein” or “hereunder”, or words of similar import, mean this ATM
